semaglutide and high potassium Managing hyperkalemia in the outpatient setting Managing Potassium Levels While Using

While GLP-1 drugs can result in 15-25% total body weight loss, surgery often achieves 25-35% or more, with higher rates of long-term maintenance and remission of related diseases

Similarly, tirzepatide, another GLP-1 and GIP receptor agonist (branded as Mounjaro for diabetes and Zepbound for weight loss), shares many of semaglutides mechanisms and considerations

Health Canada Black Box Warning Thyroid C-Cell Tumours Rybelsus carries a Health Canada black box warning regarding thyroid C-cell tumours the most serious regulatory warning category

The autoimmune attack destroys cells in the stomach that produce a vital protein called intrinsic factor